Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.420
-0.020 (-0.58%)
At close: Feb 21, 2025, 4:00 PM
3.400
-0.020 (-0.58%)
After-hours: Feb 21, 2025, 4:29 PM EST
Arbutus Biopharma Employees
Arbutus Biopharma had 73 employees as of December 31, 2023. The number of employees decreased by 25 or -25.51% compared to the previous year.
Employees
73
Change (1Y)
-25
Growth (1Y)
-25.51%
Revenue / Employee
$92,356
Profits / Employee
-$1,050,685
Market Cap
648.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ABUS News
- 23 days ago - Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr. - Seeking Alpha
- 5 weeks ago - Arbutus Provides 2025 Corporate and Financial Update - GlobeNewsWire
- 6 weeks ago - Arbutus: Positive Imdusiran Data Leads To Phase 2B Development - Seeking Alpha
- 2 months ago - Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - Business Wire
- 3 months ago - Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - GlobeNewsWire
- 3 months ago - Arbutus' Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - GlobeNewsWire
- 3 months ago - Arbutus to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call Transcript - Seeking Alpha